Hawaii Legislature overrides Gov. Lingle's veto of prescription drug importation program

NewsGuard 100/100 Score

Hawaii lawmakers last week overrode Gov. Linda Lingle's (R) veto of a bill that will enroll the state in I-SaveRx, a program that allows residents to purchase lower-cost prescription drugs from other countries, the AP/Honolulu Advertiser reports.

Hawaii is the sixth state to enroll in the program, which began in Illinois in 2004 and can provide savings of up to 55%.

It will be available to all state residents by July 1, 2009.

Critics of the program said that they were concerned about the safety of drugs from other countries and that they were not sure whether it is legal.

According to the AP/Advertiser, "Although it's illegal to import drugs that don't comply with the federal government's labeling requirements or haven't been granted federal approval, federal authorities so far haven't gone after I-SaveRx" (Niesse, AP/Honolulu Advertiser, 5/9).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine